أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - latanoprost; timolol maleate - eye drops, solution - 50mcg/ml + 5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - latanoprost - eye drops, solution in single-dose container - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - latanoprost; timolol - eye drops, solution - 50mcg/ml + 5 milligram(s)/millilitre - beta blocking agents1); timolol, combinations - ophthalmological-betablocking agents - timolol, combinations - reduction of intraocular pressure (iop) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - latanoprost - eye drops, solution - 50 microgram(s)/millilitre - prostaglandin analogues1); latanoprost

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dodecahydrate; purified water; benzalkonium chloride; hydrochloric acid; monobasic sodium phosphate dihydrate; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: purified water; sodium hydroxide; dibasic sodium phosphate dodecahydrate; benzalkonium chloride; monobasic sodium phosphate dihydrate; sodium chloride; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

generics (uk) limited - latanoprost, timolol - eye drops solution - 50mcg/ml + 5 mg/ml - beta blocking agents

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.